As of Wednesday, Cellebrite DI Ltd.’s (NASDAQ:CLBT) stock closed at $5.70, up from $5.52 the previous day. While Cellebrite DI Ltd. has overperformed by 3.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLBT rose by 26.95%, with highs and lows ranging from $6.22 to $3.80, whereas the simple moving average jumped by 13.85% in the last 200 days.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Analysis of Cellebrite DI Ltd. (CLBT)
Further, the quarter-over-quarter increase in sales is 14.10%, showing a positive trend in the upcoming months.
One of the most important indicators of Cellebrite DI Ltd.’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 1.50, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CLBT is recording 144.99K average volume. On a monthly basis, the volatility of the stock is set at 5.04%, whereas on a weekly basis, it is put at 6.40%, with a gain of 2.52% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.53, showing growth from the present price of $5.70, which can serve as yet another indication of whether CLBT is worth investing in or should be passed over.
How Do You Analyze Cellebrite DI Ltd. Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 73.72%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 18.60% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in CLBT shares?
The recent increase in stakes in CLBT appears to be a result of several institutional investors and hedge funds increasing their positions. Excellence Investments Ltd.’s position in CLBT has increased by 6.60% in the first quarter. The company now owns 6,347,537 shares of the stock, with a value of $34.34 million, following the purchase of 392,849 additional shares during the last quarter. Greenhaven Road Investment Manage made another decreased to its shares in CLBT during the first quarter, downing its stake by -1.57%. During the last quarter, the company picked up -56,256 additional shares for a total stake of worth $19.06 million, bringing number of shares owned by the company to 3,522,958.
During the first quarter, Crosslink Capital, Inc. added a 9,923 position in CLBT. Light Street Capital Management L sold an additional -1.2 million shares in the last quarter, decreasing its holdings by -29.70%, now holding 2.84 million shares worth $15.38 million. At the end of the first quarter, Isomer Partners LP decreased its CLBT holdings by -11.32% and now holds 2.62 million CLBT shares valued at $14.2 million with the lessened -0.34 million shares during the period. CLBT shares are owned by institutional investors to the tune of 18.60% at present.
